Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Medical Oncology
•
Internal Medicine
•
Hematology
•
Benign Hematology
How do you treat an adult with Diamond-Blackfan anemia that is steroid refractory, transfusion dependent, and not a candidate for transplant?
Related Questions
In which cases would you consider early transition to DOAC (within 72 hours) for hospitalized patients with intermediate or high risk PE?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
Do you use direct oral anticoagulants to treat port-a-cath related VTE in patients with an active malignancy?
How would you treat suspected secondary HLH in patients whom etoposide is contraindicated?
Would you complete a bone marrow biopsy for an unexplained macrocytosis without anemia?
Would you anticoagulate an SMV thrombosis caused by malignant obstruction in the setting of metastatic colorectal cancer?
How would one approach concomitant diffuse large B cell lymphoma and fibrotic phase myelofibrosis?
How would you manage elevated vWF and FVIII levels in a patient with a family history of coagulopathy?
Do you give Ra-223 (Xofigo) to patients diagnosed as having benign neutropenia (ANC 1.0-1.5) who are otherwise eligible to receive this radioisotope?
What is the consensus on giving Pemivibart for Pre-Exposure COVID prophylaxis in immunocompromised patients?
